Bone Biologics Co. (OTC:BBLG – Get Free Report) shares shot up 13% on Friday . The stock traded as high as $1.19 and last traded at $1.11. 375,913 shares changed hands during mid-day trading, an increase of 41% from the average session volume of 265,956 shares. The stock had previously closed at $0.98.
Bone Biologics Stock Up 13.0 %
The stock has a market cap of $2.77 million, a price-to-earnings ratio of -0.02 and a beta of 0.45. The stock has a fifty day moving average of $1.19 and a two-hundred day moving average of $1.45.
Bone Biologics Company Profile
Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein. The company's NELL-1/DBM, an osteopromotive recombinant protein that provides target specific control over bone regeneration. It also develops NELL-1/DBM Fusion Device for use in spinal fusion procedures in skeletally mature patients with spinal degenerative disc disease at one level from L2-S1.
Featured Stories
- Five stocks we like better than Bone Biologics
- What is a SEC Filing?
- Cold Front, Hot Stocks: Diesel Prices Propel Energy Leaders
- The Basics of Support and Resistance
- Sustainable and Successful: 3 Climate ETFs Beating the Market
- What Are Dividend Challengers?
- Quantum Opportunity: Skywater Technology’s Long-Term Potential
Receive News & Ratings for Bone Biologics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bone Biologics and related companies with MarketBeat.com's FREE daily email newsletter.
